MyD88 signalling is critical in the development of pancreatic cancer cachexia
Abstract Background Up to 80% of pancreatic cancer patients suffer from cachexia, a devastating condition that exacerbates underlying disease, reduces quality of life, and increases treatment complications and mortality. Tumour‐induced inflammation is linked to this multifactorial wasting syndrome,...
Saved in:
Main Authors: | Xinxia Zhu (Author), Kevin G. Burfeind (Author), Katherine A. Michaelis (Author), Theodore P. Braun (Author), Brennan Olson (Author), Katherine R. Pelz (Author), Terry K. Morgan (Author), Daniel L. Marks (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2019-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Soyasaponins reduce inflammation by downregulating MyD88 expression and suppressing the recruitments of TLR4 and MyD88 into lipid rafts
by: Junbin Chen, et al.
Published: (2020) -
Simultaneous targeting of MyD88 and Nur77 as an effective approach for the treatment of inflammatory diseases
by: Uzma S, et al.
Published: (2016) -
Cryptotanshinone from Salvia miltiorrhiza Bunge (Danshen) inhibited inflammatory responses via TLR4/MyD88 signaling pathway
by: Xin-Xing Li, et al.
Published: (2020) -
LXR agonist inhibits inflammation through regulating MyD88 mRNA alternative splicing
by: Ni Li, et al.
Published: (2022) -
Melatonin modulates TLR4/MyD88/NF-κB signaling pathway to ameliorate cognitive impairment in sleep-deprived rats
by: Chao Yin, et al.
Published: (2024)